01354nam 2200361Ia 450 991069883010332120090527105754.0(CKB)5470000002397567(OCoLC)352878758(EXLCZ)99547000000239756720090527d2003 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humansRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2003]ii, 60 pages digital, PDF fileTitle from PDF title page (viewed on May 27, 2009)."Final guidance"."April 2003".Includes bibliographical references (pages 56-60).Guidance for industry XenograftsGovernment policyUnited StatesXenograftsGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698830103321Guidance for industry3434577UNINA